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journal homepage: www.e- jmii .comLETTER TO THE EDITORSkin and soft tissue infection caused by
Aeromonas species in cancer patientsTo the Editor,
We read with great interest the article by Papadakis et al,1
published in the Journal of Microbiology, Immunology, and
Infection, who reported a patient with fulminate Aero-
monas hydrophila soft tissue infection and septicemia
during acute lymphoblastic leukemia treatment. After
combination therapy with antibiotics and surgical man-
agement, the patient recovered well. The case reminds us
of the possibility of Aeromonas infection in cancer patients;
however, knowledge about this clinical entity is limited.
This study was intended to investigate retrospectively the
clinical manifestation of Aeromonas-related skin and soft
tissue infections (SSTIs) in cancer patients to understand
this issue better.
This study was conducted at the Chi Mei Medical Center,
a 900-bed hospital. This hospital is located in southern
Taiwan,2 where the Aeromonas infection is endemic, and
most of the patients treated at the hospital are cancer
patients. This retrospective study enrolled patients with
culture-confirmed Aeromonas infection during the period
January 2009eDecember 2011. SSTIs were diagnosed in
patients who presented with pain, swelling of the involved
site, and patchy, edematous, erythematous, or bullous skin
lesions. Necrotizing fasciitis was defined as necrosis of the
subcutaneous tissue and adjacent fascia due to severe
infection. All isolates were identified by conventional
methods and verified further following the procedure
described in our previous study.3 Polymicrobial infections
were diagnosed in patients from whom Aeromonas species,
in addition to other pathogens, were isolated from cuta-
neous specimens. In-hospital mortality was defined as
death due to any cause during hospitalization.
A total of 129 patients with SSTIs caused by Aeromonas
species were enrolled in the study, including 121684-1182/$36 Copyright ª 2013, Taiwan Society of Microbiology. Publ
http://dx.doi.org/10.1016/j.jmii.2013.02.006patients (9.3%) with underlying malignancy. Clinical
manifestations of these 12 cancer patients with Aero-
monas SSTIs are summarized in Table 1. Most of the pa-
tients were male (n Z 9, 75%), with two-thirds of them
being elderly patients (aged greater than 65 years).
A. hydrophila (n Z 6, 50.0%) was the most common
pathogen, followed by Aeromonas veronii biovar sobria
(n Z 3, 25.0%), Aeromonas caviae (n Z 2, 16.7%), and
Aeromonas veronii biovar veronii (n Z 1, 8.3%). Hepato-
cellular carcinoma was the most common malignancy,
followed by cholangiocarcinoma, and gastric cancer. In
addition to cancer, diabetes mellitus (n Z 3) and liver
cirrhosis (n Z 3) were the most common underlying dis-
eases. Among these patients, 58.3% (n Z 7) had trauma-
related wound infections, and only one patient had a
history of exposure to aqueous environments prior to
infection. Only two patients presented with necrotizing
fasciitis. The majority (n Z 10, 83.3%) of patients had
polymicrobial SSTIs. The outcome was favorable with an
appropriate antibiotic therapy with in vitro activity, with
or without surgical intervention, except in one patient
with A. caviae infection who had in-hospital mortality.
In the present work, we had two important findings.
Firstly, although liver cirrhosis and diabetes mellitus are
the most common underlying diseases, which predispose
patients to Aeromonas infections,4,5 the present work and
Papadakis et al’s1 report show that Aeromonas can cause
SSTIs in patients with malignancy, including both solid and
hematological cancers. Secondly, consistent with our
previous study,3 most of the cases were caused by poly-
microbial infections. Despite these patients being immu-
nocompromised, the outcomes combined with this
infection were good in this series.
In conclusion, Aeromonas species should be considered
as an etiology of SSTIs among cancer patients.ished by Elsevier Taiwan LLC. All rights reserved.
Table 1 Clinical manifestations of 12 cancer patients with skin and soft tissue infections caused by Aeromonas species
Patient
no. (year)
Age/sex Underlying conditions Aeromonas species Trauma Polymicrobial
infection
Antibiotic Surgical
treatment
Amputation ICU
admission
Acute
respiratory
failure
In-hospital
mortality
1 (2009) 79/M Gastric cancer,
receiving chemotherapy
A. veronii biovar
sobria
No Yes Ceftazidime Yes No Yes Yes No
2 (2009) 47/M Esophageal cancer,
receiving chemotherapy
A. hydrophila No Yes Ceftazidime No No No No No
3 (2009) 64/M Cholangiocarcinoma,
DM, receiving
chemotherapy
A. caviae No Yes Ciprofloxacin No No Yes Yes Yes
4 (2010) 86/F Liver cirrhosis, HCC A. veronii biovar
sobria
Yes No Ceftriaxone No No No No No
5 (2010) 77/M Gastric cancer A. hydrophila Yes No Ciprofloxacin Yes No No No No
6 (2010) 71/F DM, tongue cancer A. hydrophila Yes Yes Ciprofloxacin Yes No No No No
7 (2010) 77/M Ureteral cancer A. veronii biovar
veronii
Yes Yes Ciprofloxacin Yes No No No No
8 (2010) 89/M Lip cancer, receiving
chemotherapy
A. caviae No Yes Ceftriaxone No No No No No
9 (2011) 81/M Rectal cancer A. hydrophila Yes Yes Ceftazidime Yes No Yes No No
10 (2011) 63/M Cholangiocarcinoma A. veronii biovar
sobria
No Yes Ceftazidime No No Yes Yes No
11 (2011) 75/F DM, liver cirrhosis, HCC A. hydrophila Yes Yes Ciprofloxacin Yes No Yes Yes No
12 (2011) 61/M Liver cirrhosis, HCC A. hydrophila Yes Yes Ceftazidime Yes No No No No
DM Z diabetes mellitus; F Z female; HCC Z hepatocellular carcinoma; ICU Z intensive care unit; M Z male.
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